Free tool
Healthcare stocks
We cover 58 companies in the Healthcare sector. The median market value in the group is $23.40M. Across the group, the median move over the past trading day is +0.66%. 81% of the 58 with a 200-day average trade above it. Price change over the past year runs from −43.3% to +137.8% across the middle 80 percent of the group, with a median of +10.2%.
Other lists in this group
Table
58 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| MRCK34.SA | Merck & Co., Inc. | 101.37 BRL | +20.05% | +39.73% | +81.07% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| AMGN34.SA | Amgen Inc. | 81.32 BRL | +13.94% | +69.69% | +47.79% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | 67.15 BRL | +9.49% | −0.22% | +22.22% |
| DWTX | Dogwood Therapeutics, Inc. | $2.66 | +71.61% | −37.26% | −42.80% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | 1,145.00 JPY | +12.48% | +7.77% | −23.84% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| INCR | InterCure Ltd. | $5.95 | +546.74% | +477.67% | +265.03% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | 13.70 SEK | +13.41% | −28.65% | −11.27% |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | 311.00 JPY | +15.61% | +9.43% | +1.97% |
| 4584.T | Kidswell Bio Corporation | 179.00 JPY | +29.71% | −15.57% | −26.03% |
| PRPO | Precipio, Inc. | $30.41 | +34.12% | +27.64% | +99.25% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| ENP.AX | Entropy Neurodynamics Limited | 0.04 AUD | +17.14% | +28.12% | +10.81% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| 4583.T | Chiome Bioscience Inc. | 86.00 JPY | +26.47% | −19.63% | −36.76% |
| HBIO | Harvard Bioscience, Inc. | $7.65 | +29.22% | +17.69% | +44.34% |
| AREC.L | Arecor Therapeutics plc | 66.00 GBP | +3.94% | −22.35% | +3.94% |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% |
| SIGHT.PA | GenSight Biologics S.A. | 0.12 EUR | +46.83% | +5.61% | −25.31% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | 1.75 SEK | +32.27% | −13.13% | −44.31% |
| TXMD | TherapeuticsMD, Inc. | $2.28 | +10.68% | +38.18% | +103.57% |
| RENX.L | Renalytix Plc | 4.30 GBP | +62.26% | −27.12% | −26.50% |
| RUA.L | RUA Life Sciences plc | 28.00 GBP | +9.80% | +103.64% | +130.93% |
| ALTAO.PA | Aton | 0.02 EUR | +94.12% | +182.86% | +153.85% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| PMI | Picard Medical, Inc. | $9.80 | +122.73% | +438.46% | +113.51% |
| VYNE | VYNE Therapeutics Inc | $28.56 | +3080.40% | +4824.14% | +8660.74% |
| 5619.T | MRSO INC | 900.00 JPY | +1.35% | +1.69% | −16.43% |
| EZZ.AX | EZZ Life Science Holdings Limited | 0.56 AUD | +15.63% | −61.66% | −77.25% |
| LEXX | Lexaria Bioscience Corp. | $11.04 | +36.30% | +1588.07% | +1146.05% |
| BCDA | BioCardia, Inc. | $1.19 | +52.56% | −6.30% | −38.66% |
| 7813.T | Platz Co., Ltd. | 877.00 JPY | +10.04% | +9.76% | +18.51% |
| CMMB | Chemomab Therapeutics Ltd. | $2.59 | +81.12% | +44.69% | −25.57% |
| BTC.AX | BTC Health Limited | 0.06 AUD | +15.09% | −1.61% | −1.61% |
| ICR.AX | Intelicare Holdings Limited | 0.03 AUD | +26.09% | +20.83% | +75.76% |
| GSS.AX | Genetic Signatures Limited | 0.09 AUD | +50.00% | −64.49% | −71.00% |
| ICO.ST | Iconovo AB (publ) | 1.26 SEK | +26.00% | +12.50% | −52.09% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $0.98 | +59.61% | +14.89% | −38.75% |
| LUCY | Lucyd, Inc | $1.13 | +52.50% | −0.88% | −42.05% |
| FBLG | FibroBiologics, Inc. | $1.41 | +116.92% | −70.62% | −88.25% |
| 7090.T | Ligua Inc. | 911.00 JPY | +12.05% | −2.46% | −15.65% |
| XBIO | Xenetic Biosciences, Inc. | $3.86 | +54.40% | +79.53% | +35.92% |
| SKYE | Skye Bioscience, Inc. | $2.02 | +228.46% | +130.07% | −41.62% |
| CURX | Curanex Pharmaceuticals Inc | $4.60 | +2223.23% | +1150.00% | −1.29% |
| IXC.AX | Invex Therapeutics Ltd | 0.13 AUD | +18.18% | +4.00% | +30.00% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.33 | +710.86% | +426.12% | +211.51% |
| FDBK.L | Feedback plc | 6.85 GBP | +13.22% | −36.28% | −48.30% |
| BIAF | bioAffinity Technologies, Inc. | $5.09 | +710.51% | +317.21% | −31.59% |
| SCNI | Scinai Immunotherapeutics Ltd. | $2.87 | +987.12% | +293.15% | +93.92% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.